GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biomark Diagnostics Inc (XCNQ:BUX) » Definitions » Deferred Policy Acquisition Costs

Biomark Diagnostics (XCNQ:BUX) Deferred Policy Acquisition Costs


View and export this data going back to 2014. Start your Free Trial

What is Biomark Diagnostics Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Biomark Diagnostics Business Description

Traded in Other Exchanges
Address
130 - 3851 Shell Road, Richmond, BC, CAN, V6X 2W2
Biomark Diagnostics Inc is a Canada-based oncology-focused company. It is engaged in the development of the early-stage cancer diagnostic technology platform. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor, and assess early cancer treatment. Its research and development are focused on the role that metabolomics plays in early cancer detection. The company's objective is to commercialize its inventive technology. and strive to increase the predictive accuracy in early-stage cancer detection.
Executives
Guoyu Huang Senior Officer
Rashid Ahmed Maula Bux Director